FMC CORP 8-K

What Happened

• FMC Corporation announced on June 18, 2026 that it entered into a framework agreement to sell underutilized buildings and land on the Delaware portion of its Stine Research Center campus in Newark, DE to Ercor Elkton, LLC for gross cash proceeds of approximately $114 million. The sale is subject to a due diligence period, customary closing conditions and adjustments, and is expected to close in the fourth quarter of 2026.
• The parties intend to negotiate a leaseback so FMC can continue operating the facilities it actively uses; FMC said core research activities and scientific infrastructure will remain in place and it does not expect any impact to its R&D capabilities. FMC will retain ownership of the adjacent Maryland property. Proceeds are expected to be used to pay down debt. FMC cautioned the agreement is preliminary and the transaction is not assured.

Key Details

• Agreement date: June 18, 2026; expected close: Q4 2026 (subject to due diligence and closing conditions).
• Buyer: Ercor Elkton, LLC; gross cash proceeds: approx. $114 million.
• Structure: sale of underutilized Delaware campus property with planned leaseback for operational facilities; FMC keeps adjacent Maryland property.
• Use of proceeds: expected to be used to reduce debt; transaction terms (including leaseback) remain subject to negotiation and may change.

Why It Matters

• The deal would monetize underutilized real estate to generate cash (≈ $114M) that FMC expects to use to pay down debt, which could strengthen the balance sheet.
• FMC says research operations at the Stine Research Center will continue without disruption and R&D capabilities are expected to remain intact, reducing operational risk from the sale.
• Important caveat for investors: the agreement is a preliminary framework subject to due diligence and negotiation, so the transaction (and final economic terms) is not guaranteed; FMC’s forward-looking statements are subject to the risks and qualifications noted in its 2025 Form 10-K.